Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia
Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia
Recruiting · NCT06604520 · Registry updated 2026-03-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia | Frontotemporal Lobar Degeneration, Nutritional and Metabolic Diseases, Pick disease, TDP-43 proteinopathy, brain disorder, central nervous system disorder, cognitive disorder, dementia, frontotemporal dementia, metabolic disease, nervous system disorder, neurodegenerative disease, proteostasis deficiencies, psychiatric disorder | Recruiting | Phase 2 | 2026-03-09 | NCT06604520 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Johns Hopkins University | 579 |
| Lundbeck LLC | 1 |
| National Institute on Aging (NIA) | 571 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Johns Hopkins Hospital | Baltimore | United States | 26 |